These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3198194)

  • 1. Approaches to the development of assays for interaction of tobacco-specific nitrosamines with haemoglobin and DNA.
    Hecht SS; Carmella SG; Trushin N; Spratt TE; Foiles PG; Hoffmann D
    IARC Sci Publ; 1988; (89):121-8. PubMed ID: 3198194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine.
    Carmella SG; Hecht SS
    Cancer Res; 1987 May; 47(10):2626-30. PubMed ID: 3567895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone released from human haemoglobin as a dosimeter for exposure to tobacco-specific nitrosamines.
    Hecht SS; Kagan SS; Kagan M; Carmella SG
    IARC Sci Publ; 1991; (105):113-8. PubMed ID: 1855833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue.
    Murphy SE; Heiblum R
    Carcinogenesis; 1990 Sep; 11(9):1663-6. PubMed ID: 2205411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical studies on tobacco smoke LVI. Tobacco specific nitrosamines: origins, carcinogenicity and metabolism.
    Hecht SS; Chen CB; Ornaf RM; Hoffmann D; Tso TC
    IARC Sci Publ (1971); 1978; (19):395-413. PubMed ID: 680735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations on the molecular dosimetry of tobacco-specific N-nitrosamines.
    Hecht SS; Carmella SG; Trushin N; Foiles PG; Lin D; Rubin JM; Chung FL
    IARC Sci Publ; 1987; (84):423-9. PubMed ID: 3679413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tobacco-specific N-nitrosamines.
    Adams JD; Lavoie EJ; O'Donnell M; Hoffmann D
    IARC Sci Publ; 1984; (57):779-85. PubMed ID: 6533065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin adducts as biomarkers of exposure to and metabolic activation of carcinogenic tobacco-specific nitrosamines.
    Hecht SS; Carmella SG; Murphy SE
    Biomed Environ Sci; 1991 Jun; 4(1-2):93-103. PubMed ID: 1910605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the tobacco specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
    Hecht SS; Chen CB; Young R; Lin D; Hoffmann D
    IARC Sci Publ; 1980; (31):755-65. PubMed ID: 7228296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats.
    Tyroller S; Zwickenpflug W; Thalheim C; Richter E
    Toxicology; 2005 Nov; 215(3):245-53. PubMed ID: 16118032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of tobacco-specific nitrosamines by cultured rat nasal mucosa.
    Brittebo EB; Castonguay A; Furuya K; Hecht SS
    Cancer Res; 1983 Sep; 43(9):4343-8. PubMed ID: 6871868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus.
    Murphy SE; Heiblum R; Trushin N
    Cancer Res; 1990 Aug; 50(15):4685-91. PubMed ID: 2369743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines.
    Hecht SS; Carmella SG; Foiles PG; Murphy SE
    Cancer Res; 1994 Apr; 54(7 Suppl):1912s-1917s. PubMed ID: 8137311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
    Fischer S; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compounds.
    Carmella SG; Kagan SS; Spratt TE; Hecht SS
    Cancer Res; 1990 Sep; 50(17):5453-9. PubMed ID: 2201436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine.
    Hecht SS; Spratt TE; Trushin N
    Carcinogenesis; 1988 Jan; 9(1):161-5. PubMed ID: 3335041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans.
    Hecht SS; Carmella SG; Foiles PG; Murphy SE; Peterson LA
    Environ Health Perspect; 1993 Mar; 99():57-63. PubMed ID: 8319660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative carcinogenicity in F344 rats of the tobacco-specific nitrosamines, N'-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.
    Hecht SS; Chen CB; Ohmori T; Hoffmann D
    Cancer Res; 1980 Feb; 40(2):298-302. PubMed ID: 7356512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies in tobacco carcinogenesis.
    Hoffmann D; Melikian AA; Brunnemann KD
    IARC Sci Publ; 1991; (105):482-4. PubMed ID: 1855901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.